KALEIGH KNOX: Open Payments
NPI 1629825419 · SALINA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,480 in 113 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $663 · 2025 $1,480
Food & beverage: $1,480
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 39 | $307 |
| Novo Nordisk Inc | 16 | $200 |
| Lilly USA, LLC | 12 | $156 |
| ABBVIE INC. | 12 | $143 |
| Xeris Pharmaceuticals, Inc. | 4 | $82 |
| Corcept Therapeutics | 4 | $79 |
| SANOFI-AVENTIS U.S. LLC | 3 | $65 |
| Tandem Diabetes Care, Inc. | 3 | $53 |
| Chiesi USA, Inc. | 2 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $45 |
Products named: Omnipod, MOUNJARO, GVOKE HYPOPEN, Korlym, Rybelsus, TZIELD, Ozempic, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across KS — which companies pay providers there.
